Editorial

Editorial Comment on Djaladat's "The Effect on Aminophylline of Renal Colic"

Authors: Edward D. Kim, MD

Abstract

In this well-designed study, Djaladat et al1 compared intravenous (IV) aminophylline infusion to placebo for pain control in patients presenting to an emergency room with acute renal colic. Using a visual analog scale, they reported that pain intensity was effectively controlled in 64% of treated patients compared with 17% of patients receiving placebo. Side effects were mild and infrequently reported.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Djaladat H, Tajik P, Fard S, et al. The effect of aminophylline on renal colic: a randomized double blind controlled trial. South Med J 2007;100:1081–1084.
 
2. Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol 2007;177:983–987.
 
3. Larkin GL, Peacock 4th, WF Pearl SM, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med 1999;17:6–10.